Industry: Pharmaceuticals Region: Europe Transaction Price: US $1million Method of transaction: Equity investment
The underlying situation
The target company is a leading European manufacturer of infusion drugs, focusing on the development of patient specific infusion solutions.
The target company works closely with clinics, medical institutions, nursing homes and pharmacies to provide patients with all nationally licensed oncology drugs, antibiotics, or assistive devices, etc., to ensure the best care for patients.
The underlying business
All of the company's infusion solutions are made in accordance with the highest European standards, in advanced dust-free laboratories and under aseptic conditions, completely from the national approved medicinal finished products, with the best quality and meet the highest quality standards.
The company also pays attention to staff training. New hires will undergo a tailored introductory training course lasting several weeks, while regular, targeted training and refresher courses are provided to all employees as required.
During the entire production process, the company strictly monitors the production conditions, including air pressure, humidity and pathogen load. The company has a license to manufacture clinical research drugs and has extensive experience in the manufacture of clinical research drugs.
Cooperation intention
The company is interested in selling. Please contact us if you are interested.